Evidence map›Paper›PMID 39066400›Full record

ArticleVaccines2024

Factors Associated with Uptake of Routine Measles-Containing Vaccine Doses among Young Children, Oromia Regional State, Ethiopia, 2021.

Abyot Bekele Woyessa, Monica P Shah, Binyam Moges Azmeraye, Jeff Pan, Leuel Lisanwork, Getnet Yimer, Shu-Hua Wang, J Pekka Nuorti, Miia Artama, Almea M Matanock and 14 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Abyot Bekele WoyessaOromia Regional Health Bureau, Addis Ababa P.O. Box 24341, Ethiopia.ORCID 0000-0003-3585-1625
Monica P ShahGlobal Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
Binyam Moges AzmerayeGlobal One Health Initiative, Ohio State University, Addis Ababa P.O. Box 1176, Ethiopia.
Jeff PanCollege of Medicine, Ohio State University, Columbus, OH 43210, USA.
Leuel LisanworkGlobal One Health Initiative, Ohio State University, Addis Ababa P.O. Box 1176, Ethiopia.
Getnet YimerGlobal One Health Initiative, Ohio State University, Addis Ababa P.O. Box 1176, Ethiopia.ORCID 0000-0002-1469-837X
Shu-Hua WangCollege of Medicine, Ohio State University, Columbus, OH 43210, USA.ORCID 0000-0001-8006-2401
J Pekka NuortiHealth Sciences Unit, Faculty of Social Sciences, Tampere University, 33100 Tampere, Finland.
Miia ArtamaHealth Sciences Unit, Faculty of Social Sciences, Tampere University, 33100 Tampere, Finland.
Almea M MatanockGlobal Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
Qian AnGlobal Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
Paulos SamuelOromia Regional Health Bureau, Addis Ababa P.O. Box 24341, Ethiopia.
Bekana ToleraOromia Regional Health Bureau, Addis Ababa P.O. Box 24341, Ethiopia.
Birhanu KenateOromia Regional Health Bureau, Addis Ababa P.O. Box 24341, Ethiopia.ORCID 0000-0003-0326-5971
Abebe BekeleOromia Regional Health Bureau, Addis Ababa P.O. Box 24341, Ethiopia.
Tesfaye DetiOromia Regional Health Bureau, Addis Ababa P.O. Box 24341, Ethiopia.
Getachew WakoUNICEF, Addis Ababa P.O. Box 1169, Ethiopia.
Amsalu ShiferawUNICEF, Addis Ababa P.O. Box 1169, Ethiopia.
Yohannes Lakew TeferaMinistry of Health of Ethiopia, Addis Ababa P.O. Box 1234, Ethiopia.
Melkamu Ayalew KokebieMinistry of Health of Ethiopia, Addis Ababa P.O. Box 1234, Ethiopia.
Tatek Bogale AnbessieAfrican Field Epidemiology Network, Addis Ababa P.O. Box 12874, Ethiopia.ORCID 0009-0004-3135-8635
Habtamu Teklie WubieEthiopian Public Health Institute, Addis Ababa P.O. Box 1242, Ethiopia.
Aaron WallaceGlobal Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.ORCID 0000-0003-2264-3229
Ciara E SugermanGlobal Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.

Funding

Gavi Though the Ethiopia Targeted Country Assistance, Partner Engagement Framework and from the US Centers for Disease Control and Prevention
6 · The paper itself

Abstract

Recommended vaccination at nine months of age with the measles-containing vaccine (MCV1) has been part of Ethiopia's routine immunization program since 1980. A second dose of MCV (MCV2) was introduced in 2019 for children 15 months of age. We examined MCV1 and MCV2 coverage and the factors associated with measles vaccination status. A cross-sectional household survey was conducted among caregivers of children aged 12-35 months in selected districts of Oromia Region. Measles vaccination status was determined using home-based records, when available, or caregivers' recall. We analyzed the association between MCV1 and MCV2 vaccination status and household, caregiver, and child factors using logistic regression. The caregivers of 1172 children aged 12-35 months were interviewed and included in the analysis. MCV1 and MCV2 coverage was 71% and 48%, respectively. The dropout rate (DOR) from the first dose of Pentavalent vaccine to MCV1 was 22% and from MCV1 to MCV2 was 46%. Caregivers were more likely to vaccinate their children with MCV if they gave birth at a health facility, believe that their child had received all recommended vaccines, and know the required number of vaccination visits and doses. MCV2 coverage was low, with a high measles dropout rate (DOR). Caregivers with high awareness of MCV and its schedule were more likely to vaccinate their children. Intensified demand generation, defaulter tracking, and vaccine-stock management should be strengthened to improve MCV uptake.

Indexed as

barriersdropout rateEthiopiaimmunization coverageMCV1MCV2measlesmeasles-containing vaccineOromiasecond year of life

Identifiers

PMID39066400
PMCPMC11281473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.